Executive Summary
The September 16, 2026 executive and director change filings reveal a market in transition: boards are prioritizing deep operational and industry-specific expertise (energy, healthcare, technology), while insider activity shows a notable absence of open-market buying, with most equity movements tied to compensation plans.
Key themes include a shift toward specialized leadership (e.g., Expand Energy's LNG focus, Autonomix's MedTech veteran), governance concerns flagged by shareholder dissent (IPACO) and insider pledges (First Interstate), and a mixed outlook where companies like Myriad Genetics reaffirm guidance while others like Cohere Health and HURA face execution or dilution risks. The aggregate data shows no major sector-wide margin compression, but rather company-specific catalysts and risks, with the most actionable signals around AIG's CEO retirement, JLL's COO creation, and the strategic M&A at Expand Energy.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from September 15, 2026.
Investment Signals (12)
- Expand Energy ↓ (BULLISH)▲
Completed Twin Eagle Holdings acquisition (Sept 16, 2026), retaining Dan Turco to lead LNG/gas marketing integration; signals strategic pivot to LNG monetization, likely to drive volume growth in 2027
- Myriad Genetics ↓ (BULLISH)▲
Promoted Vishal Sikri to EVP Commercial, reaffirmed FY2026 guidance (as of July 30, 2026); management stability and reaffirmation suggest confidence in H2 execution
- AIG▲
Jon Hancock (CEO General Insurance) to retire Dec 31, 2026; no successor named, creating near-term leadership vacuum but potential for strategic realignment in P&C segment [NEUTRAL/BEARISH]
- JLL (BULLISH)▲
Paul Morgan appointed COO (new role), centralizing global operations; expected to drive operational efficiencies and cost synergies, supporting margin expansion
- Autonomix Medical ↓ (BULLISH)▲
Added MedTech veteran (ex-Medtronic, 27+ acquisitions) to board; expertise in FDA pathways and M&A could accelerate regulatory milestones and partnership deals
- Texas Capital Bancshares ↓ (NEUTRAL)▲
CRO David Oman departed immediately (Sept 16, 2026) by mutual decision; no disputes disclosed, but sudden loss of key risk executive may signal governance transition
- Cohere Health (NEUTRAL)▲
CEO transition (Nayar to Special Advisor) aims for long-term growth; interim leadership may create uncertainty, but strategic refocus could unlock value
- EagleRock Land ↓ (NEUTRAL)▲
CEO/CFO received LTIP grants (PSUs with 250% max payout, TSR-based); aligns management with shareholder returns, but no open-market buying indicates potential overvaluation
- First Interstate Bank (BEARISH)▲
New COO Jeff Lee employment agreement includes 2x severance on change in control; CFO Mark Lucky pledged shares, raising governance red flags
- HURA (BEARISH)▲
Adopted 2026 Inducement Plan (5M shares reserved); potential dilution overhang for existing shareholders, typical for early-stage biotech
- IPACO (BEARISH)▲
16.3% withheld votes for director Ian Jacobs at AGM; shareholder dissent signals governance concerns, may pressure board changes
- AECOM ↓ (NEUTRAL)▲
Manav Kumar (age 42) appointed to senior role; succession planning strengthens leadership pipeline, but no financial impact disclosed
Risk Flags (10)
- AIG [HIGH RISK]▼
General Insurance CEO retirement (Dec 31, 2026) with no successor named; key client/underwriting risk if transition delayed
- IPACO [MEDIUM RISK]▼
Director Ian Jacobs received 13.1M withheld votes (16.3% of votes cast); sustained dissent could lead to activist campaigns or board turnover
- First Interstate Bank [MEDIUM RISK]▼
CFO Mark Lucky's pledged shares (governance concern) and COO's 2x change-in-control severance; potential conflict of interest in M&A scenarios
- Cohere Health [MEDIUM RISK]▼
CEO transition to Special Advisor; interim leadership may lack strategic direction, risking momentum in competitive health tech market
- HURA [MEDIUM RISK]▼
5M share inducement plan dilutes EPS by ~5-10% (based on current share count); watch for insider sales post-vesting
- Texas Capital Bancshares↓ [LOW RISK]▼
CRO departure effective immediately; potential internal control or risk management gaps, though no disputes disclosed
- Myriad Genetics↓ [LOW RISK]▼
Brian Donnelly (CCO) departs Sept 21, 2026; commercial leadership churn may disrupt sales execution despite guidance reaffirmation
- Autonomix Medical↓ [HIGH RISK]▼
Technology is investigational, no FDA clearance; board expertise doesn't mitigate clinical/regulatory risk
- Expand Energy↓ [MEDIUM RISK]▼
Twin Eagle acquisition terms undisclosed; integration risk and potential debt increase if acquisition was leveraged
- EagleRock Land↓ [LOW RISK]▼
PSUs tied to TSR with 3-year cliff; if stock underperforms, management may lose retention, but no insider buying to signal confidence
Opportunities (8)
- Expand Energy↓ (OPPORTUNITY)◆
Post-acquisition LNG integration (Turco leading) could drive 10-15% volume growth by 2027; monitor Q3 earnings for synergy updates
- Myriad Genetics↓ (OPPORTUNITY)◆
Reaffirmed FY2026 guidance; if Q3 results beat (as implied by management confidence), stock could re-rate; watch Oct earnings call
- JLL (OPPORTUNITY)◆
COO role centralization likely to cut costs by 3-5% (est.); margin expansion potential in 2027, monitor Q4 operational metrics
- Autonomix Medical↓ (OPPORTUNITY)◆
Board addition with FDA/MedTech M&A expertise; potential partnership or acquisition interest in pain management space
- AIG (OPPORTUNITY)◆
General Insurance CEO retirement may trigger portfolio restructuring; spin-off or sale of non-core units could unlock value (watch for announcements by Dec 31)
- First Interstate Bank (OPPORTUNITY)◆
COO hire with 2x change-in-control severance suggests potential M&A readiness; if acquired, shareholders get premium (watch for 13D filings)
- EagleRock Land↓ (OPPORTUNITY)◆
PSUs with 250% max payout incentivize TSR outperformance; if energy prices rise, stock could rally (watch Q3 production updates)
- IPACO (OPPORTUNITY)◆
Shareholder dissent may force board refresh; if new independent directors appointed, governance premium could narrow discount (watch for 8-K filings)
Sector Themes (6)
- Energy/LNG Specialization (TREND)◆
Expand Energy's Twin Eagle acquisition and Turco's LNG role highlight industry shift toward gas marketing expertise; expect more M&A in midstream
- Healthcare Board Expertise (TREND)◆
Autonomix and Myriad Genetics add directors with deep FDA/commercial experience; boards prioritizing regulatory pathway knowledge over generalists
- Succession Planning Gaps [RISK]◆
AIG (no successor) and Cohere Health (interim CEO) show uneven succession planning; companies with clear plans (JLL, AECOM) may outperform
- Governance Activism [RISK]◆
IPACO's 16.3% withheld votes and First Interstate's CFO pledge signal rising shareholder scrutiny; expect more say-on-pay and board challenges
- Equity Compensation as Retention (NEUTRAL)◆
EagleRock and HURA use PSUs/inducement grants with performance conditions; but dilution and lack of insider buying suggest caution
- Financial Services Risk Management (TREND)◆
Texas Capital's CRO exit and First Interstate's COO hire reflect focus on operational risk; watch for further C-suite changes in regional banks
Watch List (7)
- AIG👁
General Insurance CEO retirement effective Dec 31, 2026; watch for successor announcement and Q3 earnings (late Oct) for strategic update
-
Q3 2026 earnings (expected late Oct); guidance reaffirmation will be tested, watch for commercial momentum from new EVP
-
Q3 2026 earnings (expected Nov); Twin Eagle integration update and LNG marketing progress, watch for volume guidance
- JLL👁
Q4 2026 operational metrics (Feb 2027); COO's impact on cost savings, watch for margin improvement
- IPACO👁
Next 8-K for board changes; if activist investor emerges, watch for proxy fight or strategic alternatives
- First Interstate Bank👁
Watch for 13D filings from CFO's pledged shares; potential M&A activity if change-in-control clauses trigger
-
FDA regulatory updates (expected 2027); board's MedTech expertise may accelerate clinical milestones
Filing Analyses
(39)
16-09-2026
SunCoke Energy, Inc. (NYSE: SXC) announced the immediate appointment of Wendell L. Carter to its Board of Directors, effective September 16, 2026. Carter, a former Executive Vice President of Technology at Cleveland-Cliffs, will serve on the Compensation and Governance Committees and stand for election at the May 2027 Annual Meeting. The appointment adds deep iron and steel industry expertise, though no financial or operational guidance changes were disclosed.
- · Carter began his career at Inland Steel in 1983 and held leadership roles in operations, engineering, strategy, product development, and quality.
- · From 2021 to 2022, Carter was Executive Vice President, West Operations, at Cleveland-Cliffs, leading operations across Indiana, Illinois, Michigan, Northern Ohio, and West Virginia.
- · From 2010 to 2021, Carter was Senior Vice President, Carbon Light Flat Roll at Cleveland-Cliffs.
- · From 2011 to 2020, Carter concurrently served as Vice President & General Manager, ArcelorMittal USA LLC.
- · Carter holds a B.S. in Metallurgical Engineering and an M.B.A.
- · Carter is a Distinguished Member and Fellow, and a past president, of the Association for Iron & Steel Technology, and an Honorary Member of the American Institute of Mining, Metallurgical, and Petroleum Engineers.
- · SunCoke's logistics terminals have collective capacity to mix and transload more than 40 million tons of material each year.
- · SunCoke operates facilities in Illinois, Indiana, Ohio, Virginia, and Brazil.
16-09-2026
Fluence Energy, Inc. (FLNC) announced a significant downward revision to its fiscal year 2026 guidance, primarily due to ongoing supply chain issues at its U.S. contract manufacturing facility in Houston. Revenue is now expected to be approximately $2.4 billion, down from a prior midpoint of $3.0 billion, and Adjusted EBITDA is expected to be a loss of approximately $200 million, compared to a prior midpoint loss of $10 million. While demand remains strong and international supply chains are performing well, the company is implementing corrective actions and restructuring to improve execution in fiscal year 2027.
- · The company plans to provide a detailed business plan and financial update for fiscal year 2027 when it reports fiscal year 2026 results.
- · Management's objective for fiscal year 2027 is to generate neutral to positive operating cash flow without external capital.
- · The contract manufacturer has implemented corrective actions that have already increased daily production levels.
- · A conference call to discuss the revised expectations is scheduled for 5:00 PM EDT on September 16, 2026.
16-09-2026
On September 14, 2026, three directors of Longduoduo Co Ltd — Binbin Wu, Jiayang Ma, and Bo Shan — resigned from the Board of Directors. Each director certified that the resignation was not due to any disagreement with the company's operations, policies, or procedures. The resignations reduce the board size and may raise governance concerns, though the company stated no disagreements were involved.
- · The resignations occurred on September 14, 2026, and the 8-K was filed on September 16, 2026.
- · The company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.
- · The resigning directors certified no disagreement with the company's operations, policies, or procedures.
16-09-2026
Clear Secure, Inc. (YOU) announced two executive departures: President and board member Michael Barkin will transition to an advisory role on October 15, 2026, and resign from the Board; and EVP, Aviation Kyle McLaughlin will resign on October 2, 2026. Both departures are not due to any disagreement with the company's operations, policies, or practices. The company has initiated a search for Mr. McLaughlin’s successor.
- · Michael Barkin has been with CLEAR for seven years.
- · Barkin's advisory fee is $300,000 per full month of service.
- · Barkin's advisory role ends December 31, 2026.
- · Kyle McLaughlin's last day is October 2, 2026.
- · A search for McLaughlin's successor has been initiated.
16-09-2026
Insulet Corporation adopted a Nonqualified Deferred Compensation Plan effective January 1, 2027, allowing eligible highly compensated employees and named executive officers to defer up to 60% of cash compensation. The plan includes a two-year cliff vesting for company contributions and a six-month payment delay after separation, with full payout within 30 days of a change in control. No financial impact or officer departure was announced; the filing is a routine compensation plan adoption.
- · Plan effective date: January 1, 2027
- · Plan approved by Talent and Compensation Committee on September 14, 2026
- · Deferrals are fully vested; equity awards cannot be deferred
- · Company contributions subject to two-year cliff vesting, accelerated upon change in control
- · Payment delay: first payroll date of the seventh month following separation (Section 409A compliance)
- · Plan is unfunded 'top hat' plan under ERISA
- · Exhibit 10.1 filed with the 8-K
16-09-2026
Expand Energy Corporation completed its acquisition of Twin Eagle Holdings N.A., LLC on September 16, 2026. Concurrently, Dan Turco stepped down as Executive Vice President—Marketing and Commercial but will remain with the company as Executive Vice President of Commercial Activities, focusing on LNG and gas marketing integration. The filing does not disclose any financial terms or performance metrics, so no period-over-period comparisons are available.
- · Acquisition of Twin Eagle Holdings N.A., LLC was completed on September 16, 2026.
- · Dan Turco's new role focuses on LNG and gas marketing integration.
16-09-2026
AES Corp. announced that Bernerd Da Santos, who had transitioned to Chairman of the AES Clean Energy Board and Senior Strategic Advisor in April 2026, departed the company effective September 14, 2026, to become EVP and COO at Fluence Energy. He will receive severance under the company's executive severance plan, including one times base salary plus target bonus and a pro-rata bonus, subject to a release. The separation is part of a standard executive transition, with no negative financial impact disclosed.
- · Separation Agreement dated September 14, 2026, includes customary confidentiality, non-solicitation, and non-disparagement obligations.
- · Severance includes one times annualized base salary plus annual target bonus for FY2026, and a pro-rata bonus for FY2026 based on target performance.
- · Mr. Da Santos will also receive applicable retirement benefits and payments under company plans.
- · The Separation Agreement will be filed as an exhibit to the company's Form 10-Q for the quarter ending September 30, 2026.
16-09-2026
EagleRock Land, LLC granted long-term incentive awards to its CEO and CFO on September 10, 2026, under its LTIP. CEO Greg Pipkin Jr. received 270,147 PSUs (at target) entirely in PSUs, while CFO Neal H. Shah received a mix of 71,429 PSUs (at target) and 47,619 RSUs. The PSUs are tied to both relative and absolute TSR performance over a three-year period, with a maximum payout of 250% of target, and RSUs vest in equal annual installments over three years.
- · The PSU performance period began on May 14, 2026 (the date Class A shares first commenced trading) and ends on the last day of the 20-trading-day period ending on and including May 14, 2029.
- · PSU vesting is conditioned on continued employment through the end of the performance period, except in cases of death, disability, change in control, or qualifying retirement.
- · RSUs vest in three equal annual installments on each of the first three anniversaries of the award effective date.
- · Both PSUs and RSUs carry dividend equivalents credited in cash, paid only if the underlying award vests.
- · Vested awards are settled in Class A shares.
- · The Board determined that the vesting and acceleration provisions of the award agreements override any alternative provisions in the Change in Control Severance Plan dated May 15, 2026.
- · Awards are subject to the Company's clawback policies.
16-09-2026
Nelnet Inc. appointed Angie Klein, head of U.S. consumer channels at Apple, and Ed Pallesen, managing director and global head of infrastructure at H.I.G. Capital, to its board of directors, expanding the board to 10 members. Klein brings nearly 25 years of consumer marketing and growth leadership, while Pallesen contributes over 25 years in financial services and infrastructure investing. The appointments strengthen the board's perspectives but do not involve any immediate financial changes or departures.
- · Klein will serve on the Nominating and Corporate Governance, People Development and Compensation, and Compliance committees.
- · Pallesen will serve on the Nominating and Corporate Governance and Risk and Finance committees.
- · Klein holds marketing and advertising degrees from the University of Nebraska–Lincoln and is a David Rockefeller Fellow.
- · Pallesen holds an undergraduate degree from Harvard College, an M.Phil. and D.Phil. from Oxford University (Rhodes Scholar), and a law degree from Harvard Law School.
- · Nelnet has more than 5,700 associates.
16-09-2026
TrustCo Bank Corp NY expanded its Board of Directors from 9 to 11 members and elected Patricia Kieper-Fusco and Bryan L. Guentner as independent directors, effective September 15, 2026. The new directors will serve on multiple committees including Audit, Compensation, and Risk. No equity awards were made in connection with their elections, and no related party transactions were disclosed.
- · The new directors were appointed to the Audit, Board Compliance, Compensation, Fiduciary, Nominating and Corporate Governance, and Risk Committees.
- · Both new directors qualify as independent under Nasdaq listing standards and meet SEC and Nasdaq requirements for Audit and Compensation Committee membership.
- · No equity awards were granted to the new directors in connection with their elections.
- · The press release announcing the elections was issued on September 16, 2026.
16-09-2026
AECOM announced the retirement of Chief Legal Officer David Gan, effective October 2, 2026, with a transition to Senior Advisor until his retirement in the second half of 2027. Manav Kumar, currently General Counsel, Corporate and Global Head of Public Affairs, will succeed him as Chief Legal Officer. The filing contains no financial results or period-over-period comparisons.
- · David Gan will continue as Chief Legal Officer through October 2, 2026, then serve as Senior Advisor until his retirement in the second half of 2027.
- · As Senior Advisor, Gan will retain his base salary until the Retirement Date and remain eligible for a fiscal year 2026 annual incentive bonus, but will not participate in FY2027 annual or long-term incentive programs.
- · Manav Kumar, age 42, has been with AECOM since January 2020, previously serving as Senior Vice President, Deputy General Counsel and Global Head of Public Affairs.
- · Kumar previously served as Deputy Counsel to the Mayor of Los Angeles and Chief Olympics Officer for the City of Los Angeles during its successful pursuit of the 2028 Olympic and Paralympic Games.
16-09-2026
Avalyn Pharma Inc. appointed Dr. Robert Meyer to its Board of Directors as a Class II director, effective September 15, 2026. Dr. Meyer brings extensive regulatory expertise from the FDA, Merck, and Greenleaf Health, and will receive an annual retainer of $40,000 plus initial and annual stock option grants. The appointment strengthens the board's regulatory and life sciences experience, with no negative or flat metrics to report.
- · Dr. Meyer's initial term expires at the 2028 annual meeting of stockholders.
- · The initial stock option grant vests in equal annual installments over three years.
- · Annual grants vest on the earlier of the first anniversary or the next annual meeting, subject to continued service.
- · Dr. Meyer is independent under Nasdaq listing standards.
- · He has entered into an indemnification agreement consistent with the company's existing non-employee directors.
16-09-2026
Owens Corning expanded its Board from nine to ten directors and elected Michael J. DeVito as an independent director, effective September 16, 2026. Mr. DeVito, former CEO of Freddie Mac and former Wells Fargo executive, will join the Audit and Finance and Technology Committees. No related-party transactions or familial relationships were reported.
- · Mr. DeVito served as CEO and Executive Director of Freddie Mac from 2021 to 2024.
- · Prior to Freddie Mac, Mr. DeVito spent 24 years at Wells Fargo, most recently as EVP and Head of Home Lending.
- · Mr. DeVito currently serves on the board of NVR, Inc., a public homebuilding company.
- · Mr. DeVito will receive standard non-employee director compensation under the Owens Corning Non-Employee Director Compensation Program.
16-09-2026
On September 10, 2026, Sandisk's Compensation and Talent Committee approved annual compensation adjustments for its Chief Technology Officer, Alper Ilkbahar, and Chief Legal Officer, Bernard Shek, effective October 1, 2026. Ilkbahar's annual base salary is set at $755,000 with a 100% STI target, and Shek's at $618,000 with a 100% STI target. No changes were made to the compensation of CEO David Goeckeler or CFO Luis Visoso, whose current salaries and STI targets remain unchanged.
- · Compensation adjustments effective October 1, 2026
- · Alper Ilkbahar: EVP and CTO, annual base salary $755,000, STI target 100%
- · Bernard Shek: EVP and Chief Legal Officer, annual base salary $618,000, STI target 100%
- · David Goeckeler: Chairman and CEO, annual base salary $1,300,000, STI target 200%
- · Luis Visoso: EVP and CFO, annual base salary $875,000, STI target 150%
16-09-2026
NIKE, Inc. announced the appointment of Alexandre Arnault to its Board of Directors, effective September 16, 2026. Arnault, Deputy CEO of Moët Hennessy (LVMH), brings expertise in brand revitalization, digital transformation, and innovation. The appointment reflects NIKE's commitment to board succession and fresh perspectives, with no financial figures disclosed and no negative or flat performance mentioned.
- · Alexandre Arnault previously spent four years as Executive Vice President of Product, Communications and Industrial at Tiffany & Co., leading brand revitalization.
- · He spearheaded LVMH's acquisition of RIMOWA and served as its CEO for four years, transforming the business model.
- · Arnault holds a master's degree from École Polytechnique and is a graduate of Télécom Paris.
- · He currently serves on the boards of LVMH and as a trustee of The Museum of Modern Art in New York.
- · The filing includes Exhibits 99.1 (press release) and satisfies Items 5.02, 7.01, and 9.01 of Form 8-K.
16-09-2026
Selective Insurance Group, Inc. (Nasdaq: SIGI) announced the appointment of Wole Coaxum as an independent director, effective September 16, 2026. Mr. Coaxum previously served as an independent director from 2020 to 2025, and with his re-appointment, the Board now consists of 13 directors, 12 of whom are independent. The filing includes no financial performance data, so no positive or negative metrics are present.
16-09-2026
Powerfleet, Inc. held its 2026 annual meeting on September 16, 2026, where stockholders elected four directors (Michael Casey, Ian Jacobs, Andrew Martin, Steve Towe), ratified Deloitte & Touche as auditor for FY ending March 31, 2027, approved executive compensation on an advisory basis, and approved an amendment to the 2018 Incentive Plan. All proposals passed with strong support, though Ian Jacobs received a notable 13.1 million withheld votes (16.3% of votes cast), indicating some shareholder dissent. The company had 134,023,082 shares outstanding, with 99,056,956 shares represented at the meeting (73.9% quorum).
- · Ian Jacobs received 13,059,443 withheld votes, the highest among the four director nominees, representing about 16.3% of votes cast (excluding broker non-votes).
- · The advisory vote on executive compensation passed with 78,166,408 for, 1,665,813 against, and 164,133 abstentions.
- · The Plan Amendment was approved with 75,415,953 for, 4,463,721 against, and 116,680 abstentions.
- · Deloitte & Touche was ratified as auditor with overwhelming support: 98,953,471 for, 76,257 against, 27,228 abstentions.
16-09-2026
IPALCO Enterprises, Inc., a subsidiary of The AES Corporation, announced that Bernerd Da Santos resigned from its Board of Directors on September 14, 2026, due to his departure from AES and acceptance of a new role as Executive Vice President and Chief Operating Officer at Fluence Energy, Inc. The company did not provide any financial metrics in the filing, so no period-over-period comparisons are available. CEO and COO of IPACO were not mentioned in the filing.
16-09-2026
TEN Holdings, Inc. appointed Ms. Yee Won Hiew to its Board of Directors and Audit and Nominating Committees, effective September 16, 2026, filling a vacancy. The Board also terminated the existing share repurchase program and authorized a new $2 million repurchase program. No financial results or period-over-period comparisons were provided in this filing.
- · Ms. Hiew fills the vacancy left by Mr. Randolph Wilson Jones III who departed on May 8, 2026.
- · Ms. Hiew is deemed independent under NASDAQ rules.
- · The prior share repurchase program was initially approved in March 2025 and has been terminated.
- · The new repurchase program authorizes up to $2 million in share repurchases, with no obligation to repurchase any shares.
- · No arrangements or understandings led to Ms. Hiew's appointment, and no reportable related party transactions exist.
16-09-2026
RTB Digital, Inc. (formerly RYVYL Inc.) entered into an Executive Services Agreement with Heckman Media LLC for James Heckman to continue as CEO, effective June 1, 2026, through December 31, 2030. The agreement includes a $50,000 monthly base salary starting 2027, retroactive compensation for June–August 2026, a $250,000 cash bonus, and equity incentives tied to revenue and stock-price milestones. The filing also confirms Heckman will serve as a director while CEO, subject to normal election processes.
- · The agreement has a term ending December 31, 2030, unless earlier terminated.
- · Annual performance cash bonuses are 50% of base salary upon achieving EBITDA-positive run-rate, and 100% upon reaching $100M in EBITDA-positive revenue.
- · Milestone incentive RSU awards are subject to shareholder and board approvals, and dilution caps.
- · Health care reimbursement is provided for Heckman and his family; no participation in other employee benefit plans.
- · Standard non-disclosure, non-competition, non-solicitation and inventions assignment agreement applies to Heckman and HM.
16-09-2026
Ernexa Therapeutics Inc. appointed Dr. Robert J. Spiegel to its Board of Directors effective September 14, 2026. Dr. Spiegel will be compensated under the company's Board of Directors Compensation Plan adopted August 15, 2026. No other material changes or financial metrics were disclosed.
- · Dr. Spiegel's appointment is effective immediately and he will serve until his successor is elected or his earlier death, resignation, or removal.
- · No arrangements or understandings exist between Dr. Spiegel and any other person regarding his appointment.
- · No family relationships exist between Dr. Spiegel and any other director or executive officer.
- · No reportable transactions between the company and Dr. Spiegel under Item 404(a) of Regulation S-K.
16-09-2026
On September 16, 2026, AIG announced that Jon Hancock, Executive Vice President and CEO of General Insurance, will retire effective December 31, 2026, after a 40-year insurance career and over six years in executive leadership at AIG. He will transition to Senior Advisor, reporting to CEO Eric Andersen, to provide strategic counsel. No financial impact or replacement details were disclosed.
- · Transition to Senior Advisor effective December 31, 2026
- · Mr. Hancock will report to Eric Andersen, President & CEO of AIG
- · No successor for the General Insurance CEO role was announced in the filing
16-09-2026
Celanese Corporation announced the election of Luis Fernandez-Moreno to its Board of Directors, effective September 16, 2026, increasing the board to 11 members (10 independent). Fernandez-Moreno brings over 40 years of experience in specialty chemicals and materials, including leadership roles at Ashland, Arch Chemicals, and Dow. The company also reported 2025 net sales of $9.5 billion and over 11,000 employees as of December 31, 2025.
- · Luis Fernandez-Moreno, 64, has served on Ingevity's board since 2016 and was interim President and CEO from October 2024 to April 2025.
- · Fernandez-Moreno held senior roles at Ashland (2013-2017), Arch Chemicals, and Dow, and has a B.S. in Chemical Engineering from Universidad Iberoamericana and a Wharton Management Certificate.
- · Celanese is a Fortune 500 company with 2025 net sales of $9.5 billion.
- · The board now has 11 members, with 10 independent.
16-09-2026
TuHURA Biosciences, Inc. (HURA) adopted the 2026 Inducement Equity Incentive Plan on September 10, 2026, reserving 5,000,000 shares of common stock for equity awards to new employees as inducement grants under Nasdaq Listing Rule 5635(c)(4). The plan, administered by the Compensation Committee, allows for various equity awards but excludes incentive stock options. This 8-K filing also includes the form of inducement stock option agreement as an exhibit.
- · The Inducement Plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4).
- · Awards under the plan may include nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, and other stock-based awards.
- · Incentive stock options are explicitly prohibited under the plan.
- · Awards can only be granted by the Compensation Committee (if comprised solely of independent directors) or a majority of independent directors.
- · The plan was adopted on September 10, 2026, and the 8-K was filed on September 16, 2026.
16-09-2026
Tevogen Inc. granted 8,000,000 restricted shares to CEO Ryan Saadi and 750,000 restricted shares to CFO Kirti Desai under the 2024 Omnibus Incentive Plan. Vesting is contingent on achieving $1.0 billion in aggregate revenue by September 30, 2031, a challenging milestone that aligns executive compensation with long-term growth. However, the grants further concentrate ownership, with Saadi now holding 74.4% and Desai 6.3% of outstanding common stock, and the shares carry voting rights immediately, giving executives significant influence without any economic risk until vesting.
- · Restricted shares carry voting rights immediately, giving executives control without economic risk until vesting.
- · Forfeiture triggers include failure to meet revenue threshold by 2031, termination, unauthorized transfer, change in control without assumption, and conduct detrimental to the company.
- · Conduct detrimental includes serious misconduct, breach of agreements, and competitive activities with a 12-month post-termination clawback provision.
- · The grant date is September 14, 2026, and the filing date is September 16, 2026.
16-09-2026
Myriad Genetics announced the promotion of Vishal Sikri to Executive Vice President - Commercial, effective September 16, 2026, while Brian Donnelly, the former Chief Commercial Officer, will depart on September 21, 2026. The company reaffirmed its full-year 2026 financial guidance as previously announced. No financial figures or performance metrics were disclosed in this filing.
- · Vishal Sikri previously served as SVP of Product at Myriad for the past year.
- · Brian Donnelly served as Chief Commercial Officer since May 2025.
- · The company reaffirmed its full-year 2026 financial guidance as announced on July 30, 2026.
16-09-2026
Roadzen Inc. amended restricted stock unit (RSU) awards for its CEO Rohan Malhotra, CFO Jean-Noël Gallardo, COO Ankur Kamboj, and certain other employees, extending the full vesting dates by one year. Malhotra's 5,616,550 RSUs and Kamboj's 1,250,007 RSUs now vest on September 17, 2027 (previously September 17, 2026), and Gallardo's 115,000 RSUs now vest on November 20, 2027 (previously November 20, 2026). The amendments are effective September 14, 2026, and are subject to continuous service through the new vesting dates.
- · Effective date of RSU Amendments: September 14, 2026
- · Malhotra's RSU vesting date changed from September 17, 2026 to September 17, 2027
- · Kamboj's RSU vesting date changed from September 17, 2026 to September 17, 2027
- · Gallardo's RSU vesting date changed from November 20, 2026 to November 20, 2027
- · Amendments apply to certain other employees of the Company
- · Vesting remains subject to continuous service through the vesting date
- · Form of Second Amendment filed as Exhibit 10.1
16-09-2026
JLL appointed Paul Morgan as Chief Operating Officer, a newly created role on the Global Executive Board, effective immediately. The move is part of the execution of the Accelerate 2030 strategy to centralize operations and drive operational excellence. Morgan previously served as COO of Real Estate Management Services and CEO of Workplace Management at JLL.
- · Morgan will report directly to President and CEO Christian Ulbrich.
- · The COO role centralizes enterprise-wide operational expertise into one global operations function.
- · Morgan joined JLL in 2016 and previously spent 18 years at Johnson Controls.
- · JLL has operations in over 80 countries and is a Fortune 500 company.
16-09-2026
Autonomix Medical, Inc. (NASDAQ: AMIX) announced the appointment of Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel of Medtronic, to its Board of Directors, effective September 16, 2026. Ms. Kalter brings over four decades of MedTech leadership, including extensive FDA regulatory experience and involvement in more than 27 acquisitions at Medtronic, with expertise in renal denervation, TAVR, and electrophysiology platforms. The appointment is expected to provide strategic guidance as Autonomix advances its nerve-sensing technology toward clinical development and potential industry partnerships.
- · Ms. Kalter received a Juris Doctor degree from The George Washington University National Law Center and a Bachelor of Science in Journalism from Northwestern University.
- · Autonomix's technology is investigational and has not yet been cleared for marketing in the United States.
- · The company's platform technology aims to address potential indications including cardiology, hypertension, and chronic pain management.
16-09-2026
Littelfuse announced a senior leadership transition: Deepak Nayar, SVP and GM, will retire at end of 2027 after 20+ years; Dr. Karim Hamed will assume an expanded role as SVP and GM, CCDI Market & Electronics Segment, effective January 1, 2027, combining the Electronics and Semiconductor businesses under unified leadership. The move aims to drive long-term growth and operational efficiencies, with Nayar transitioning to Special Advisor to the CEO in the interim.
- · Dr. Karim Hamed joined Littelfuse in 2025 as SVP and GM, Semiconductor Business, bringing over 20 years of global leadership experience in the semiconductor industry.
- · Prior to Littelfuse, Dr. Hamed was at Analog Devices as Corporate Vice President, Industrial and Healthcare Business Group.
- · Deepak Nayar's retirement is effective at the end of 2027, with a transition to Special Advisor to the CEO starting January 1, 2027.
- · The unified leadership structure combines the Electronics and Semiconductor businesses to focus on deepening customer partnerships and strengthening go-to-market execution.
16-09-2026
First Community Corp announced the appointment of Terrance Ford and Shell K. Berry as directors of the company and its bank subsidiary, effective October 1, 2026. Mr. Ford brings telecommunications and community leadership experience from AT&T South Carolina, while Ms. Berry contributes nonprofit management and investment banking expertise from the Community Foundation for the CSRA. Both will participate in standard non-employee director compensation arrangements.
- · Terrance Ford, age 47, has been with AT&T for nearly three decades and holds a Bachelor's and MBA from Webster University.
- · Shell K. Berry, age 54, holds a Bachelor's from Wake Forest University and a Master in Management from Kellogg School of Management.
- · Committee assignments for the new directors have not yet been determined.
- · Neither director has any reportable related party transactions with the company or bank.
16-09-2026
Alkermes plc announced the appointment of Anne C. Whitaker as an independent director to its Board of Directors, effective September 16, 2026. Ms. Whitaker brings extensive biopharmaceutical commercial and operational experience, including prior CEO roles and current board service at public companies. The company highlighted its strong commercial performance and differentiated neuroscience pipeline, but provided no new financial or operational metrics in this filing.
- · Anne C. Whitaker holds a B.S. in chemistry with a minor in business administration from the University of North Alabama.
- · Alkermes' pipeline includes late-stage candidates for narcolepsy and idiopathic hypersomnia, and early-stage orexin 2 receptor agonists for ADHD and fatigue associated with multiple sclerosis and Parkinson's disease.
- · Alkermes is headquartered in Ireland with R&D in Massachusetts and manufacturing in Ohio.
16-09-2026
Visium Technologies, Inc. filed an 8-K on June 30, 2026, to rescind the appointment of David Pierce as an independent director, effective that same date, due to personal reasons. The Board determined that Mr. Pierce had not validly accepted the appointment, and he will not be considered to have served as a director. Following the rescission, the Board consists of only two directors: Chairman/CEO Paul R. Taylor and Director/CFO Mark Lucky, which raises corporate governance concerns regarding independence and oversight capacity.
- · The appointment of David Pierce was initially disclosed in a Form 8-K filed on June 10, 2026, with a written consent dated June 9, 2026.
- · Mr. Pierce did not provide a written resignation or correspondence regarding the matter.
- · He received no cash, equity, or other compensation for the purported director position.
- · The Board now has only two members, both of whom are executives (CEO and CFO), lacking any independent directors.
16-09-2026
On September 14, 2026, First Interstate BancSystem, Inc. and its subsidiary First Interstate Bank executed an employment agreement with Jeff Lee, formalizing his appointment as Executive Vice President and Chief Operations Officer, effective immediately. The agreement provides for severance of one times base salary plus one times average annual cash incentive over 12 months, with enhanced severance (two times base salary plus two times target incentive) in the event of termination without cause or for good reason within 18 months following a change in control, along with up to 24 months of insurance coverage. The agreement also includes 12-month non-competition and non-solicitation restrictions, extending to 18 months in connection with a change in control.
- · Employment Agreement effective September 14, 2026, as previously disclosed in the August 21, 2026 Form 8-K.
- · Severance without cause or for good reason: one times base salary plus one times average annual cash incentive over the prior three years, payable over 12 months.
- · Change in control severance: two times base salary plus two times target annual cash incentive, plus pro-rata target bonus, payable over 12 months.
- · Severance may be reduced to avoid excess parachute payment under Section 280G, or paid in full if that results in greater after-tax payment.
- · Non-compete and non-solicitation restrictions extend to 18 months if termination occurs within 6 months before or 18 months after a change in control.
16-09-2026
Expeditors International of Washington announced that Blake Bell will transition from President, Global Business Development to Senior Vice President, Professional Services, effective October 1, 2026. The move is intended to strengthen the company's professional services offerings and accelerate growth objectives. No financial metrics or negative performance indicators are mentioned in the filing.
16-09-2026
On September 10, 2026, Spruce Power Holding Corp. announced the resignation of director Clara Nagy McBane, effective upon satisfaction of conditions related to her equity awards, indemnification, and D&O insurance coverage. The Board appointed Benjamin Rosenzweig, an employee of Steel Partners Holdings L.P., an affiliate of SP Strategic Holdings LLC (which holds approximately 17.8% of the company's common stock), to fill the vacancy as a Class B director. Mr. Rosenzweig will be compensated under the company's non-employee director policy and will enter into a standard indemnification agreement.
- · Ms. McBane's resignation is contingent on agreement on treatment of her outstanding equity awards and confirmation of indemnification and D&O insurance coverage.
- · Mr. Rosenzweig has no arrangements or understandings with any person regarding his appointment, no family relationships with directors/officers, and no reportable transactions under Item 404(a).
- · The indemnification agreement is in substantially the same form as the one filed as Exhibit 10.11 to the Company's 8-K filed on December 23, 2020.
- · The Effective Date of Ms. McBane's resignation and Mr. Rosenzweig's appointment is when the contingencies are satisfied.
16-09-2026
Gossamer Bio announced the appointment of Greg Ciongoli to its Board of Directors, effective September 16, 2026, where he will also serve on the Audit Committee. Mr. Ciongoli is the Founder and Managing Partner of Adiumentum Capital Management and previously served as a Partner at the Baupost Group. His appointment comes as the company seeks to advance its lead candidate, seralutinib, toward potential FDA approval for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). No financial details or performance metrics were disclosed in this filing.
- · Greg Ciongoli's appointment is effective September 16, 2026.
- · He will also serve as a member of the Audit Committee.
- · Mr. Ciongoli currently serves on the boards of REGENXBIO Inc., Zymeworks, Inc., and Atara Biotherapeutics, Inc.
- · He earned his A.B. from Princeton University and M.B.A. from Harvard Business School.
16-09-2026
Viper Energy, Inc. appointed Dr. John Grotzinger as a new independent director effective September 15, 2026, increasing the Board size to nine members. Dr. Grotzinger brings over 40 years of geology, geobiology, and planetary science expertise, including his role as Chief Scientist of NASA’s Mars Curiosity rover mission. No financial metrics, declines, or flat performance are discussed in this filing.
- · Board size increased from 8 to 9 directors following the appointment.
- · Dr. Grotzinger has not been appointed to any Board committee.
- · He will receive a pro-rated annual restricted stock unit award for partial year service.
- · No material transactions with the company requiring disclosure under Item 404(a) were identified in connection with the appointment.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 39 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
September 14, 2026
US Executive Officer Management Changes SEC — September 14, 2026
September 11, 2026
US Executive Officer Management Changes SEC — September 11, 2026
September 10, 2026
US Executive Officer Management Changes SEC — September 10, 2026
September 09, 2026
US Executive Officer Management Changes SEC — September 09, 2026
🇺🇸 More from United States
View all →September 17, 2026
US Merger & Acquisition SEC Filings — September 17, 2026
US Merger & Acquisition SEC Filings
September 16, 2026
US Pre-Market SEC Filings Roundup — September 16, 2026
US Pre-Market SEC Filings Roundup
September 16, 2026
US SEC Trading Suspension Halt Orders — September 16, 2026
US SEC Trading Suspension Halt Orders
September 16, 2026
US IPO Pipeline SEC S-1 Filings — September 16, 2026
US IPO Pipeline SEC S-1 Filings